Your browser doesn't support javascript.
loading
A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.
Janssen, Julie M; Dorlo, T P C; Niewerth, D; Wilhelm, A J; Zwaan, C M; Beijnen, J H; Attarbaschi, A; Baruchel, A; Fagioli, F; Klingebiel, T; De Moerloose, B; Palumbo, G; von Stackelberg, A; Kaspers, G J L; Huitema, A D R.
Affiliation
  • Janssen JM; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. ju.janssen@nki.nl.
  • Dorlo TPC; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Niewerth D; Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands.
  • Wilhelm AJ; Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, The Netherlands.
  • Zwaan CM; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Beijnen JH; Department of Pediatric Oncology/Hematology, Erasmus-MC Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Attarbaschi A; ITCC Consortium, Paris, France.
  • Baruchel A; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Fagioli F; Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.
  • Klingebiel T; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Vienna, Austria.
  • De Moerloose B; Department of Pediatrics and Adolescent Medicine, Medical University Vienna, Vienna, Austria.
  • Palumbo G; Department of Pediatric Hematology, Hopital Saint Louis, Paris, France.
  • von Stackelberg A; ITCC Consortium, Paris, France.
  • Kaspers GJL; Università degli Studi di Torino, Turin, Italy.
  • Huitema ADR; Department of Pediatrics, University Hospital Frankfurt, Frankfurt am Main, Germany.
Clin Pharmacokinet ; 59(2): 207-216, 2020 02.
Article de En | MEDLINE | ID: mdl-31313068

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Érythrocytes / Leucémie-lymphome lymphoblastique à précurseurs B et T / Inhibiteurs du protéasome / Bortézomib Type d'étude: Clinical_trials Limites: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Langue: En Journal: Clin Pharmacokinet Année: 2020 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Érythrocytes / Leucémie-lymphome lymphoblastique à précurseurs B et T / Inhibiteurs du protéasome / Bortézomib Type d'étude: Clinical_trials Limites: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Langue: En Journal: Clin Pharmacokinet Année: 2020 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: Suisse